Hannah Valantine, Director: BridgeBio Pharma BBIO Planned sale · Filed 02/27

Trade details

Type: Planned sale notice
Stock: BridgeBio Pharma BBIO
Person: Hannah ValantineDirector
Planned sale date: 26/02/27
Filed: 26/02/27

$1.7M to be sold

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 01/28~03/29

Hannah Valantine's recent trades

Hannah ValantineDirector
Planned sale10b5-1 planCareDx
Planned sale10b5-1 plan
CareDx
CDNA
$856.2K
28,779 sh
$856.2K
Filed 07/16
Traded 07/16
Hannah ValantineDirector
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/24
Traded 06/22
Hannah ValantineDirector
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/24
Traded 06/23
Hannah ValantineDirector
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/23
Traded 06/23
Hannah ValantineDirector
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/22
Traded 06/22